Starling Oncology, Inc. (STLNW) Net income 2020–2025
Starling Oncology, Inc. (STLNW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$60.6MFY2025 · since FY2020: -$14.3M → -$60.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.6M | +6.3% |
| FY2024 | -$64.7M | +22.2% |
| FY2023 | -$83.1M | -54750.0% |
| FY2022 | $152,000 | +101.4% |
| FY2021 | -$10.9M | +23.7% |
| FY2020 | -$14.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice